Ohr Pharmaceuticals, Inc. (OHRP)
(Delayed Data from NSDQ)
$2.65 USD
+0.05 (1.92%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.65 USD
+0.05 (1.92%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Top Ranked Momentum Stocks to Buy for August 24th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 24th:
TherapeuticsMD (TXMD) Catches Eye: Stock Moves 5.9% Higher
by Zacks Equity Research
TherapeuticsMD, Inc. (TXMD) moved big last session, as its shares jumped almost 6% on the day.
Ohr Pharmaceutical (OHRP) Jumps: Stock Adds 15% in Session
by Zacks Equity Research
Ohr Pharmaceutical, Inc. (OHRP) moved big last session, as its shares jumped 15% on the day.
Ohr Pharmaceutical Provides Update on Squalamine Study
by Zacks Equity Research
Ohr Pharmaceutical, Inc. (OHRP), announced it plans to amend the ongoing MAKO Study evaluating Squalamine (also known as OHR-102) in wet form of age-related macular degeneration (wet-AMD).
New Strong Buy Stocks for September 30th
by Indradip Ghosh
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
5 Top Performing Stocks to Buy
by David Bartosiak
If a stock can perform in this market, imagine how it will do when things normal out